Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seprafilm cuts uterine adhesions

This article was originally published in Clinica

Executive Summary

Genzyme's Seprafilm significantly reduced gynaecological adhesions in a trial presented at the European Society for Gynaecological Endoscopy in Brussels last week (December 8th). Dr Michael Diamond, professor of obstetrics and gynaecology at Wayne State University in Detroit, said that fibroid patients treated with the film have 37% fewer lesions than untreated women. The adhesions in the treated group were also significantly less severe and smaller, he added.

Topics

UsernamePublicRestriction

Register

MT094465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel